Cargando…
The use of lipid-based nanocarriers for targeted pain therapies
Sustained delivery of analgesic agents at target sites remains a critical issue for effective pain management. The use of nanocarriers has been reported to facilitate effective delivery of these agents to target sites while minimizing systemic toxicity. These include the use of biodegradable liposom...
Autores principales: | Hua, Susan, Wu, Sherry Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836271/ https://www.ncbi.nlm.nih.gov/pubmed/24319430 http://dx.doi.org/10.3389/fphar.2013.00143 |
Ejemplares similares
-
CD44-Targeted Nanocarrier for Cancer Therapy
por: Kesharwani, Prashant, et al.
Publicado: (2022) -
Extracellular vesicles derived from host and gut microbiota as promising nanocarriers for targeted therapy in osteoporosis and osteoarthritis
por: Cheung, Kenneth Chat Pan, et al.
Publicado: (2023) -
Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment
por: Battogtokh, Gantumur, et al.
Publicado: (2018) -
Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine
por: Zhang, Chengcheng, et al.
Publicado: (2022) -
Lipid-Based Nanocarriers in Renal RNA Therapy
por: Su, Chi-Ting, et al.
Publicado: (2022)